Methods and compositions relating to CD39-like polypeptides and nucleic acids
AssigneeNuvelo, Inc.
InventorsBrian Paul Chadwick, Anna-Maria Frischauf
Life of this patent
Estimating the term…
Abstract
The present invention provides polynucleotides and proteins encoded by such polynucleotides, along with therapeutic, diagnostic and research utilities for these polynucleotides and proteins. In particular, the polypeptides and polynucleotides of the invention comprise amino acid and nucleic acid sequences of novel CD39-like gene and gene products.
Claims11
An isolated CD39L4 polynucleotide comprising the nucleotide sequence of SEQ ID NO:
- 5.
An isolated polynucleotide comprising the nucleotide sequence of SEQ ID NO:
- 5 that encodes the amino acid sequence of SEQ ID NO:
- 6.
An isolated polynucleotide comprising the nucleotide sequence of SEQ ID NO:
- 5 that encodes the amino acid sequence of SEQ ID NO:
- 6, or the mature protein portion thereof, said amino acid sequence having phosphohydrolase activity.
An isolated polynucleotide encoding a polypeptide having phosphohydrolase activity, wherein said polynucleotide hybridizes under highly stringent conditions, wherein said conditions are hybridization to a filter-bound DNA in 0.5 M NaHPO4, 7% sodium dodecyl sulfate (SDS), 1 mM EDTA at 65° C., and washing in 0.1×SSC/0.1% SDS at 68° C., to the complement of SEQ ID NO:
- 5.
A host cell genetically engineered to contain a polynucleotide comprising the nucleotide sequence of SEQ ID NO:
- 5 that encodes the amino acid sequence of SEQ ID NO:
- 6 in operative association with a regulatory sequence that controls expression of the polynucleotide in the host cell.
Dependencies are inferred from the claim text.